×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
SLN – silence therapeutics plc - american depository share (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
SLN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/7
08:13 am
sln
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Low
Report
Silence Therapeutics plc (NASDAQ: SLN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
3/5
09:33 am
sln
Silence Therapeutics plc (NASDAQ: SLN) had its price target lowered by analysts at Morgan Stanley from $49.00 to $45.00. They now have an "overweight" rating on the stock.
Medium
Report
Silence Therapeutics plc (NASDAQ: SLN) had its price target lowered by analysts at Morgan Stanley from $49.00 to $45.00. They now have an "overweight" rating on the stock.
3/5
08:00 am
sln
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
Medium
Report
Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference
3/4
01:23 pm
sln
Silence Therapeutics plc (NASDAQ: SLN) had its price target lowered by analysts at BMO Capital Markets from $67.00 to $25.00. They now have an "outperform" rating on the stock.
Low
Report
Silence Therapeutics plc (NASDAQ: SLN) had its price target lowered by analysts at BMO Capital Markets from $67.00 to $25.00. They now have an "outperform" rating on the stock.
3/4
09:54 am
sln
Silence Therapeutics plc (NASDAQ: SLN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $6.00 to $4.00. They now have a "sell" rating on the stock.
Medium
Report
Silence Therapeutics plc (NASDAQ: SLN) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $6.00 to $4.00. They now have a "sell" rating on the stock.
3/1
07:07 pm
sln
Silence Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Low
Report
Silence Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
2/27
08:17 am
sln
Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update [Yahoo! Finance]
2/27
07:30 am
sln
Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Medium
Report
Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/28
05:10 pm
sln
Form 8-K Southland Holdings, Inc. For: Mar 26
Low
Report
Form 8-K Southland Holdings, Inc. For: Mar 26
3/19
04:59 pm
sln
Form 8-K Southland Holdings, Inc. For: Mar 13
Low
Report
Form 8-K Southland Holdings, Inc. For: Mar 13
3/6
11:03 am
sln
Form 4 Silence Therapeutics For: Mar 05 Filed by: Griffiths Richard Ian
Low
Report
Form 4 Silence Therapeutics For: Mar 05 Filed by: Griffiths Richard Ian
3/5
04:42 pm
sln
Form S-3 Southland Holdings, Inc.
Low
Report
Form S-3 Southland Holdings, Inc.
3/4
05:15 pm
sln
Form 10-K Southland Holdings, Inc. For: Dec 31
Low
Report
Form 10-K Southland Holdings, Inc. For: Dec 31
3/4
05:09 pm
sln
Form 8-K Southland Holdings, Inc. For: Mar 04
Low
Report
Form 8-K Southland Holdings, Inc. For: Mar 04
2/27
04:31 pm
sln
Form 10-K Silence Therapeutics For: Dec 31
Medium
Report
Form 10-K Silence Therapeutics For: Dec 31
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: